{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:23:29Z","timestamp":1780410209609,"version":"3.54.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1233330"],"award-info":[{"award-number":["UG1233330"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 CA098252"],"award-info":[{"award-number":["P50 CA098252"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA180822"],"award-info":[{"award-number":["U10CA180822"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA180868"],"award-info":[{"award-number":["U10CA180868"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ygyno.2025.09.014","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T22:24:26Z","timestamp":1759789466000},"page":"102-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Patient-reported outcomes of a randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I\/IIA cervical cancer patients treated with initial radical hysterectomy and pelvic lymphadenectomy (NRG\/GOG-0263)"],"prefix":"10.1016","volume":"202","author":[{"given":"Dana M.","family":"Chase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Q.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wui-Jin","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"William","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Mayadev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Leath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Monk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beob-Jong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Heum","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Weon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hong","family":"No","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Holman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Stuckey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Fabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra H.","family":"Smick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lari","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Young","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ygyno.2025.09.014_bb0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1999.5387","article-title":"A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic oncology group study","volume":"73","author":"Sedlis","year":"1999","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2025.09.014_bb0010","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2025.09.014_bb0015","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1477-7525-4-85","article-title":"The FDA guidance for industry on PROs: the point of view of a pharmaceutical company","volume":"31","author":"Arpinelli","year":"2006","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.ygyno.2025.09.014_bb0020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ejca.2022.03.016","article-title":"EMPOWER CERVICAL-1: effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer","volume":"174","author":"Oaknin","year":"2022","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2025.09.014_bb0025","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1470-2045(23)00052-9","article-title":"Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"24","author":"Monk","year":"2023","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2025.09.014_bb0030","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/ijgc-2019-001134","article-title":"Quality of life of locally advanced cervical cancer patients after neoadjuvant chemotherapy followed by chemoradiation versus chemoradiation alone (CIRCE trial): a randomized phase II trial","volume":"30","author":"Nunes de Arruda","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"220","key":"10.1016\/j.ygyno.2025.09.014_bb0035","doi-asserted-by":"crossref","first-page":"115375","DOI":"10.1016\/j.ejca.2025.115375","article-title":"Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: quality of life outcomes of the GCIG INTERLACE trial","volume":"2","author":"Eminowicz","year":"2025","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2025.09.014_bb0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1200\/JCO.24.00440","article-title":"Sexual Health and Quality of Life in Patients with Low-Risk Early-Stage Cervical Cancer: Results From GCIG\/CCTG CX.5\/SHAPE Trial Comparing Simple Versus Radical Hysterectomy","volume":"43","author":"Ferguson","year":"2025","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2025.09.014_bb0045","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1470-2045(20)30081-4","article-title":"Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trial","volume":"21","author":"Frumovitz","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2025.09.014_bb0050","doi-asserted-by":"crossref","unstructured":"Ryu SY, Deng W, Albuquerque K, et al. Randomized phase III trial of adjuvant radiation versus chemo-radiation in intermediate-risk, early-stage cervical carcinoma following radical hysterectomy and lymphadenectomy (results of NRG oncology\/GOG-263). SGO (Society of Gynecologic Oncology). 3\/14\/2025. Plenary Session Oral Presentation.","DOI":"10.1016\/j.ygyno.2025.03.053"},{"key":"10.1016\/j.ygyno.2025.09.014_bb0055","series-title":"Functional Assessment of Cancer Therapy \u2013 Cervix (FACT-Cx) [Internet]. Version 4. Evanston (IL)","author":"FACIT.org","year":"2025"},{"key":"10.1016\/j.ygyno.2025.09.014_bb0060","series-title":"Functional Assessment of Cancer Therapy\/Gynecologic Oncology Group \u2013 Neurotoxicity 4 Item Version (FACT\/GOG-NTX-4) [Internet]. Version 4","author":"FACIT.org","year":"2025"},{"issue":"1","key":"10.1016\/j.ygyno.2025.09.014_bb0065","first-page":"52","article-title":"The brief pain inventory (BPI)","volume":"62","author":"Poquet","year":"2016","journal-title":"Aust. J. Phys."},{"key":"10.1016\/j.ygyno.2025.09.014_bb0070","first-page":"248","article-title":"The international assessment of health-related quality of life: theory","volume":"22","author":"Fitzpatrick","year":"1996","journal-title":"Translat. Measurem. Analys. J. Medi. Ethics"},{"issue":"3","key":"10.1016\/j.ygyno.2025.09.014_bb0075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF00433915","article-title":"Multilingual translation of the functional assessment of Cancer therapy (FACT) quality of life measurement system","volume":"5","author":"Bonomi","year":"1996","journal-title":"Qual. Life Res."},{"issue":"2","key":"10.1016\/j.ygyno.2025.09.014_bb0080","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/0163278705275342","article-title":"A comprehensive method for the translation and cross-cultural validation of health status questionnaires","volume":"28","author":"Eremenco","year":"2005","journal-title":"Eval. Health Prof."},{"issue":"6","key":"10.1016\/j.ygyno.2025.09.014_bb0085","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000079497","article-title":"Development of a cancer pain assessment tool in Korea: a validation study of a Korean version of the brief pain inventory","volume":"66","author":"Yun","year":"2004","journal-title":"Oncology"},{"key":"10.1016\/j.ygyno.2025.09.014_bb0090","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/biomet\/75.4.800","article-title":"A sharper Bonferroni procedure for multiple tests of significance","volume":"75","author":"Hochberg","year":"1988","journal-title":"Biometrika"},{"key":"10.1016\/j.ygyno.2025.09.014_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2019.04.039","article-title":"Adjuvant chemoradiotherapy versus radiotherapy in cervical cancer patients with intermediate-risk factors: a systematic review and meta-analysis","volume":"238","author":"Li","year":"2019","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"10434","key":"10.1016\/j.ygyno.2025.09.014_bb0100","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(24)00317-9","volume":"403","author":"Lorusso","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ygyno.2025.09.014_bb0105","first-page":"213","article-title":"A phase III study of transdermal Granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiation","volume":"29","author":"Armbruster","year":"2021","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2025.09.014_bb0110","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ijrobp.2024.04.070","article-title":"Application of recombinant human superoxide dismutase in radical concurrent Chemoradiotherapy for cervical Cancer to prevent and treat radiation-induced acute rectal injury: a multicenter, randomized, open-label, prospective trial","volume":"120","author":"Zhu","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"11","key":"10.1016\/j.ygyno.2025.09.014_bb0115","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/ejcn.2016.102","article-title":"The efficacy and safety of probiotics for prevention of chemoradiotherapy-induced diarrhea in people with abdominal and pelvic cancer: a systematic review and meta-analysis","volume":"70","author":"Wang","year":"2016","journal-title":"Eur. J. Clin. Nutr."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582501011X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582501011X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:39:04Z","timestamp":1780407544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082582501011X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":23,"alternative-id":["S009082582501011X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.09.014","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-reported outcomes of a randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I\/IIA cervical cancer patients treated with initial radical hysterectomy and pelvic lymphadenectomy (NRG\/GOG-0263)","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}